Real-world study of the efficacy and safety of bevacizumab for first-line and post-first-line treatment of advanced RAS mutated colorectal cancer

ABSTRACT: Interventions: experimental group:chemotherapy combined with bevacizumab Primary outcome(s): Progression-Free Survival;Overall Survival Study Design: Sequential

DISEASE(S): Colorectal Cancer

PROVIDER: 2702727 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR